Efficacy of Oral Ribavirin in Lung Transplant Patients With Respiratory Syncytial Virus Lower Respiratory Tract Infection
نویسندگان
چکیده
منابع مشابه
Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview.
OBJECTIVE To systematically review the evidence evaluating the efficacy of aerosolized ribavirin for the treatment of infants with respiratory syncytial virus lower respiratory tract infection. DESIGN A computerized search of MEDLINE from 1975 to the present, a review of the reference lists of each retrieved article, and contact with experts. PATIENTS infants with documented respiratory syn...
متن کاملRibavirin in respiratory syncytial virus infection
At a recent workshop on infection the indications for ribavirin were discussed. Ribavirin has recently been licensed for hospital use in the United Kingdom having previously been available only on a named patient basis. Nebulised ribavirin is being vigorously promoted by the United Kingdom marketing company, Brittania Pharmaceuticals, for selected use in respiratory syncytial virus infections l...
متن کاملRESPIRATORY INFECTION Seasonality of long term wheezing following respiratory syncytial virus lower respiratory tract infection
Background: It is well known that respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) is associated with subsequent wheezing episodes, but the precise natural course of wheezing following RSV LRTI is not known. This study aimed to determine the continuous development of wheezing following RSV LRTI in children up to the age of 3 years. Methods: A prospective cohort study w...
متن کاملuse of ribavirin treatment in pre-transplant patients with respiratory syncytial virus upper respiratory tract infection: case report and review of literature
respiratory syncytial virus infection in immunocompromised patients, especially those with defects in cell mediated immunity is associated with high morbidity and mortality. lymphocytopenia is an important factor associated with progression of upper to lower respiratory tract infection. the only licensed antiviral treatment for rsv available currently is ribavirin, although additional immunomod...
متن کاملRibavirin for respiratory syncytial virus infection.
Over the winter of 1988, 10 infants with congenital heart disease were treated for severe bronchiolitis at Guy's Hospital. All required respiratory support of greater than 50% oxygen in a headbox, and seven required assisted ventilation. Seven patients were positive for respiratory syncytial virus, and seven received nebulised ribavirin for three to five days. There were four deaths, all infant...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Heart and Lung Transplantation
سال: 2009
ISSN: 1053-2498
DOI: 10.1016/j.healun.2008.10.008